Sjögren Syndrome: Updates From ACR 2018

What’s new in Sjögren syndrome: (1) clinical clues herald progression to a life-threatening variant and (2) a common therapy exacerbates comorbidities.

References1. Retamozo S, Flores-Chavez A, Kostov B, et al. Severe, Life-Threatening Phenotype of Primary Sjögren Syndrome: Clinical Characterization and Outcomes in 1580 Patients (GEAS-SS Registry) [Abstract 1564]. Arthritis Rheumatol. 2018;70(suppl 10). Accessed October 22, 2018.2. Baldini C, Ferro F, Luciano N, et al. Comorbidity Burden in Primary Sjögren’s Syndrome: A Long-Term Observation in Clinical Practice [Abstract 1565]. Arthritis Rheumatol. 2018;70(suppl 10). Accessed October 22, 2018.This information is brought to you by Rheumatology Network and is not sponsored by, nor a part of, the American College of Rheumatology.

Recent Videos
Gus Alva, MD | Credit: Gus Alva, MD
Gus Alva, MD | Credit: Gus Alva, MD
Gus Alva, MD | Credit: Gus Alva, MD
Gus Alva, MD | Credit: Gus Alva, MD
Gus Alva, MD | Credit: Gus Alva, MD
A panel of 5 experts on iron deficiency anemia
A panel of 5 experts on iron deficiency anemia
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
A panel of 5 experts on iron deficiency anemia
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
© 2024 MJH Life Sciences

All rights reserved.